Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB06295ExperimentalSmall molecule
Investigated for use/treatment in seborrhea, fungal infections, skin infections/disorders, and onychomycosis.
- Primary indication
- Investigated for use/treatment in seborrhea, fungal infections, skin infections/disorders, and onychomycosis.Curator reviewed
- Formula / weight
- C35H39F2N7O4 · 659.739 g/mol (avg)
- Code names
- R-126638
Resolves to
Structure
InChIKey
AEKNYBWUEYNWMJ-QWOOXDRHSA-NSMILESCC(C)N1CCN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2OC[C@@](CN3C=NC=N3)(O2)C2=CC=C(F)C=C2F)C=C1Targets
What you can answer from here — as of March 06, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Pramiconazole, and which of those have an active Phase 3 trial?